Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer

6 Jan 2017

Abstract excerpt

Non-small-cell lung carcinoma (NSCLC) accounts for 85% of malignant lung tumors and is the leading cause of cancer deaths. Our group previously identified Tripartite Motif 14 (TRIM14) as a component of a prognostic multigene expression signature for NSCLC. Little is known about the function of TRIM14 protein in normal or disease states. We investigated the functional and prognostic role of TRIM14 in NSCLC using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Response and Inflammation
Share to interferon and immune responses
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28059079
DOI: 10.1038/srep39692

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung CancerPMID 28059079Read ↗

TRIM27 promotes non-small cell lung cancer progression by enhancing P53 degradationSemantic proximity Read ↗

TRIM13 inhibits cell proliferation and induces autophagy in lung adenocarcinoma by regulating KEAP1/NRF2 pathwaySemantic proximity Read ↗

TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLCSemantic proximity Read ↗

TRIM28 in cancer and cancer therapySemantic proximity Read ↗

TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related ProteinsSemantic proximity Read ↗

The complexity of TRIM28 contribution to cancerSemantic proximity Read ↗

Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancerSemantic proximity Read ↗

Identification of TRIM56 as a Potential Biomarker for Lung AdenocarcinomaSemantic proximity Read ↗

A systematic pan-cancer analysis identifies TRIM28 as an immunological and prognostic predictor and involved in immunotherapy resistanceSemantic proximity Read ↗

Silencing of tripartite motif ( TRIM) 29 inhibits proliferation and invasion and increases chemosensitivity to cisplatin in human lung squamous cancer NCI‐H520 cellsSemantic proximity Read ↗

Expression and the potential functions of TRIM32 in lung cancer tumorigenesisSemantic proximity Read ↗

TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.